desipramine has been researched along with Dermatitis, Contact, Phototoxic in 1 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In in vivo phototoxicity testing, ultraviolet A irradiation from 3 to 6 h after oral administration of IMI (100 mg/kg) caused more potent phototoxic reactions compared with that from 0 to 3 h, and DMI yielded by metabolism of IMI would be associated with phototoxic reactions caused by orally-administered IMI." | 1.62 | An approach to evaluate metabolite-related phototoxicity with combined use of photochemical properties and skin deposition. ( Iyama, Y; Onoue, S; Sato, H; Seto, Y; Tonami, R, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seto, Y | 1 |
| Tonami, R | 1 |
| Iyama, Y | 1 |
| Sato, H | 1 |
| Onoue, S | 1 |
1 other study available for desipramine and Dermatitis, Contact, Phototoxic
| Article | Year |
|---|---|
An approach to evaluate metabolite-related phototoxicity with combined use of photochemical properties and skin deposition.
Topics: Administration, Oral; Dermatitis, Photoallergic; Dermatitis, Phototoxic; Desipramine; Imipramine; Ox | 2021 |